Price
CHART BY
Frequently asked questions
What is Inmode's market capitalization?
The market capitalization of Inmode is $856.46M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Inmode's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Inmode is 12.09. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Inmode?
Inmode's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.232. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Inmode's stock?
Currently, 6 analysts cover Inmode's stock, with a consensus target price of $16.17. Analyst ratings provide insights into the stock's expected performance.
What is Inmode's revenue over the trailing twelve months?
Over the trailing twelve months, Inmode reported a revenue of $374.63M.
What is the EBITDA for Inmode?
Inmode's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $69.89M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Inmode?
Inmode has a free cash flow of $88.40M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Inmode have, and what sector and industry does it belong to?
Inmode employs approximately 660 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Inmode's shares?
The free float of Inmode is 48.06M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $856.46M
- EPS (TTM)
- $1.232
- Free Float
- 48.06M
- P/E ratio (TTM)
- 12.09
- Revenue (TTM)
- $374.63M
- EBITDA (TTM)
- $69.89M
- Free Cashflow (TTM)
- $88.40M
Pricing
- 1D span
- $14.76$14.93
- 52W span
- $12.72$16.73
Analyst Ratings
The price target is $16.17 and the stock is covered by 6 analysts.
Buy
0
Hold
6
Sell
0
Information
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.
- Employees
- 660
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- IL0011595993
- Primary Ticker
- INMD
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet